Pacira Biosciences
PCRX
#6212
Rank
A$1.27 B
Marketcap
A$29.56
Share price
2.24%
Change (1 day)
-29.47%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: A$1.27 Billion

As of February 2026 Pacira Biosciences has a market cap of A$1.27 Billion. This makes Pacira Biosciences the world's 6212th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.27 B-28.5%
2025A$1.77 B21.92%
2024A$1.45 B-36.57%
2023A$2.29 B-11.66%
2022A$2.60 B-29.59%
2021A$3.69 B9.35%
2020A$3.38 B24.69%
2019A$2.71 B7.71%
2018A$2.51 B6.12%
2017A$2.37 B41.54%
2016A$1.67 B-56.85%
2015A$3.88 B-0.82%
2014A$3.91 B80.65%
2013A$2.16 B295.3%
2012A$0.54 B277.33%
2011A$0.14 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Pacira Biosciences was reported to be:

A$1.27 Billion
by Nasdaq info icon info icon
A$1.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
A$2.15 B 69.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
A$0.17 B-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A$1.19 B-6.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
A$0.66 B-48.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
A$0.34 B-72.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
A$11.67 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA